Individuals with Down syndrome are at increased risk of poor cardiovascular outcomes, according to a study published online ...

Wilkerson creates a kids' growth chart ruler that lasts for years, combining practical measurement with sentimental keepsake potential.

Bad Bunny's DeBÍ TiRAR Más FOToS and Fuerza Regida's 111XPANTIA hold down the No. 1 and No. 2 spots on this week's Billboard ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

Marni Rose McFall is a Newsweek reporter based in London, U.K. Her focus is on internet trends, U.S. politics and popular culture. She has covered fashion, culture, art and music extensively.

Learn More » Tenable stock is down 49% from its all-time high because ... but the number came in at $0.36 instead. It represented growth of 44% compared to the same quarter last year, which ...

Exxon Mobil Corp. and Chevron Corp. are likely to shoulder more of the Permian Basin’s oil growth as independent producers cut back due to falling crude prices. Chevron expects growth “to ...

The cloud arm reported a 16.9% increase year-on-year in quarterly revenue, to $29.27 billion, but that missed Wall Street expectations and was lower than growth reported by Google Cloud and Microsoft ...

We were seeing an incredibly good market, and now we’re seeing three, four per cent growth, maybe 5 per cent,” he said at the event at the University of Miami. “Companies are saying, ‘Oh, man, things ...

With the marketwide sell-off, plenty of red-hot growth stocks have sold off and don ... the stock will be worth far more a few years down the road. Ever feel like you missed the boat in buying ...

Mosaic Down syndrome is a variant of Down syndrome. Down syndrome is a congenital (present at birth) genetic condition that occurs when a person has three copies of chromosome 21 instead of two (the ...

We recently published a list of 11 Stocks with Consistent Growth to Buy Now. In this article, we are going to take a look at where Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) stands against ...